Albumin
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cirrhosis
Conditions
Cirrhosis, Ascites
Trial Timeline
Jul 1, 2009 → Apr 1, 2014
NCT ID
NCT00968695About Albumin
Albumin is a approved stage product being developed by Grifols for Cirrhosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00968695. Target conditions include Cirrhosis, Ascites.
What happened to similar drugs?
5 of 10 similar drugs in Cirrhosis were approved
Approved (5) Terminated (0) Active (5)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02479802 | Phase 2 | Completed |
| NCT02878733 | Pre-clinical | Completed |
| NCT00968695 | Approved | Completed |
Competing Products
20 competing products in Cirrhosis